Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Shanghai-Ark-Biopharmaceutical"

1 News Found

Rapid-acting ADHD treatment Azstarys now approved in China
Drug Approval | January 08, 2026

Rapid-acting ADHD treatment Azstarys now approved in China

ADHD is a common, chronic neurodevelopmental disorder that often begins in childhood and can persist into adulthood